Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Project Scope 

This project team will create a users guide or White Paper with recommendations for analyses and displays associated with Hepatotoxicity, with a focus on Phase 2-4 clinical trials and integrated submission documents.



Project LeadsEmail

Melvin Munsaka, AbbVie

melvin.munsaka@abbvie.com

Terry Walsh, Astellas

terry.walsh@astellas.com

Nicola Newton, PHUSE Project Assistant

nicky@phuse.global


  • Finalise Stage 1 white paper following public review.
  • Get Stage 2 white paper ready for public review

    Status
    colourBlue
    titleCurrent Status
    Q4 2024

    Q2 2025

    • Complete validation and publication of Stage 1 R programs.
    • Complete full draft white paper for Stage 2.



    Objectives & Deliverables

    Timelines 
    White PaperQ4 2023

    Finalise Stage 2 of draft White Paper